| Toward effective government communication strategies in the era of COVID-19 B Hyland-Wood, J Gardner, J Leask, UKH Ecker Humanities and Social Sciences Communications 8 (1), 2021 | 424 | 2021 |
| A history of deep brain stimulation: Technological innovation and the role of clinical assessment tools J Gardner Social studies of science 43 (5), 707-728, 2013 | 248 | 2013 |
| Aligning technology and institutional readiness: the adoption of innovation A Webster, J Gardner Technology Analysis & Strategic Management 31 (10), 1229-1241, 2019 | 91 | 2019 |
| Sociology of low expectations: recalibration as innovation work in biomedicine J Gardner, G Samuel, C Williams Science, Technology, & Human Values 40 (6), 998-1021, 2015 | 77 | 2015 |
| Patchwork diagnoses: The production of coherence, uncertainty, and manageable bodies J Gardner, K Dew, M Stubbe, T Dowell, L Macdonald Social science & medicine 73 (6), 843-850, 2011 | 70 | 2011 |
| The relationship between gambling advertising and gambling attitudes, intentions and behaviours: a critical and meta-analytic review A Bouguettaya, D Lynott, A Carter, O Zerhouni, S Meyer, I Ladegaard, ... Current Opinion in Behavioral Sciences 31, 89-101, 2020 | 61 | 2020 |
| The social management of biomedical novelty: Facilitating translation in regenerative medicine J Gardner, A Webster Social Science & Medicine 156, 90-97, 2016 | 56 | 2016 |
| The relationship between endometriosis-related pelvic pain and symptom frequency, and subjective wellbeing G Rush, RA Misajon, JA Hunter, J Gardner, KS O’Brien Health and Quality of Life Outcomes 17, 1-5, 2019 | 55 | 2019 |
| Are there specific translational challenges in regenerative medicine? Lessons from other fields J Gardner, A Faulkner, A Mahalatchimy, A Webster Regenerative medicine 10 (7), 885-895, 2015 | 49 | 2015 |
| Anticipating the clinical adoption of regenerative medicine: building institutional readiness in the UK J Gardner, A Webster, J Barry Regenerative medicine 13 (1), 29-39, 2018 | 44 | 2018 |
| Accelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy Catapult J Gardner, A Webster Science, Technology, & Human Values 42 (5), 925-946, 2017 | 38 | 2017 |
| Patient-centred medicine and the broad clinical gaze: Measuring outcomes in paediatric deep brain stimulation J Gardner BioSocieties, 2016 | 38 | 2016 |
| Promissory identities: Sociotechnical representations & innovation in regenerative medicine J Gardner, R Higham, A Faulkner, A Webster Social Science & Medicine 174, 70-78, 2017 | 37 | 2017 |
| Corporal diagnostic work and diagnostic spaces: clinicians’ use of space and bodies during diagnosis J Gardner, C Williams Sociology of health & illness 37 (5), 765-781, 2015 | 33 | 2015 |
| Responsible research and innovation: A manifesto for empirical ethics? J Gardner, C Williams Clinical ethics 10 (1-2), 5-12, 2015 | 33 | 2015 |
| Learning from deep brain stimulation: the fallacy of techno-solutionism and the need for ‘regimes of care’ J Gardner, N Warren Medicine, Health Care and Philosophy 22 (3), 363-374, 2019 | 31 | 2019 |
| Psychedelic-assisted therapies: The past, and the need to move forward responsibly J Gardner, A Carter, K O’Brien, K Seear International Journal of Drug Policy 70, 94-98, 2019 | 31 | 2019 |
| Persuasive bodies: Testimonies of deep brain stimulation and Parkinson's on YouTube J Gardner, N Warren, C Addison, G Samuel Social Science & Medicine 222, 44-51, 2019 | 30 | 2019 |
| Rethinking the Clinical Gaze: Patient-centred Innovation in Paediatric Neurology J Gardner Springer, 2017 | 29 | 2017 |
| The dispositions of things: the non‐human dimension of power and ethics in patient‐centred medicine J Gardner, A Cribb Sociology of Health & Illness 38 (7), 1043-1057, 2016 | 28 | 2016 |
Adrian CarterSchool of Psychological Sciences, Monash UniversityVerified email at monash.edu
